Financials Dicot AB

Equities

DICOT

SE0011178458

Pharmaceuticals

End-of-day quote NORDIC GROWTH MARKET 06:00:00 2024-04-29 pm EDT 5-day change 1st Jan Change
0.2495 SEK +4.83% Intraday chart for Dicot AB +19.09% -21.54%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 28.05 45.65 45.63 71.41 46.07 260
Enterprise Value (EV) 1 18.97 33.42 25.31 41.08 36.69 212.6
P/E ratio -3.6 x -2.07 x -1.7 x -1.33 x -1.27 x -3.81 x
Yield - - - - - -
Capitalization / Revenue 62.3 x 73.1 x - - - -
EV / Revenue 42.2 x 53.5 x - - - -
EV / EBITDA -3.09 x - -1.44 x -1.51 x -1.15 x -4.72 x
EV / FCF -4.62 x -3.41 x -2.58 x -2.61 x -2.05 x -7.27 x
FCF Yield -21.7% -29.3% -38.7% -38.3% -48.7% -13.8%
Price to Book 3.38 x 3.57 x 2.32 x 2.52 x 8.6 x 5.86 x
Nbr of stocks (in thousands) 7,791 16,361 43,668 102,900 137,103 817,562
Reference price 2 3.600 2.790 1.045 0.6940 0.3360 0.3180
Announcement Date 4/26/19 4/28/20 5/4/21 4/26/22 4/28/23 4/12/24
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 0.45 0.6242 - - - -
EBITDA 1 -6.148 - -17.56 -27.24 -31.79 -45.03
EBIT 1 -6.358 -13.33 -17.56 -27.25 -31.8 -45.04
Operating Margin -1,412.8% -2,135.66% - - - -
Earnings before Tax (EBT) 1 -6.343 -13.4 -17.54 -27.17 -31.76 -44.16
Net income 1 -6.343 -13.4 -17.54 -27.17 -31.76 -44.16
Net margin -1,409.51% -2,145.94% - - - -
EPS 2 -1.001 -1.349 -0.6136 -0.5225 -0.2641 -0.0834
Free Cash Flow 1 -4.109 -9.804 -9.799 -15.72 -17.86 -29.26
FCF margin -913.22% -1,570.58% - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 4/26/19 4/28/20 5/4/21 4/26/22 4/28/23 4/12/24
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 9.07 12.2 20.3 30.3 9.38 47.3
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -4.11 -9.8 -9.8 -15.7 -17.9 -29.3
ROE (net income / shareholders' equity) -157% -127% -108% -113% -188% -178%
ROA (Net income/ Total Assets) -71.2% -69.3% -61.5% -63.8% -90.1% -85.4%
Assets 1 8.91 19.33 28.51 42.58 35.26 51.71
Book Value Per Share 2 1.060 0.7800 0.4500 0.2800 0.0400 0.0500
Cash Flow per Share 2 1.160 0.7500 0.4700 0.2900 0.0700 0.0600
Capex - - 0.04 - - -
Capex / Sales - - - - - -
Announcement Date 4/26/19 4/28/20 5/4/21 4/26/22 4/28/23 4/12/24
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA